Compile Data Set for Download or QSAR
Found 97 of ec50 for UniProtKB: P33534
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235813(US9359399, 27)copy SMILEScopy InChI
Affinity DataEC50:  0.00560nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235795(US9359399, 7)copy SMILEScopy InChI
Affinity DataEC50:  0.0120nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235812(US9359399, 26)copy SMILEScopy InChI
Affinity DataEC50:  0.0194nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235803(US9359399, 16)copy SMILEScopy InChI
Affinity DataEC50:  0.0210nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235815(US9359399, 31)copy SMILEScopy InChI
Affinity DataEC50:  0.0216nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235792(US9359399, 36)copy SMILES
Affinity DataEC50:  0.0234nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235802(US9359399, 15)copy SMILEScopy InChI
Affinity DataEC50:  0.0280nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235811(US9359399, 25)copy SMILEScopy InChI
Affinity DataEC50:  0.0314nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235786(US9359399, 13)copy SMILEScopy InChI
Affinity DataEC50:  0.0320nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235784(US9359399, 5)copy SMILEScopy InChI
Affinity DataEC50:  0.0340nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235818(US9359399, 35)copy SMILEScopy InChI
Affinity DataEC50:  0.0359nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235810(US9359399, 24)copy SMILEScopy InChI
Affinity DataEC50:  0.0360nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235794(US9359399, 6)copy SMILEScopy InChI
Affinity DataEC50:  0.0360nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235804(US9359399, 17)copy SMILEScopy InChI
Affinity DataEC50:  0.0390nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235787(US9359399, 1)copy SMILEScopy InChI
Affinity DataEC50:  0.0430nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235796(US9359399, 8)copy SMILEScopy InChI
Affinity DataEC50:  0.0430nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235814(US9359399, 29)copy SMILEScopy InChI
Affinity DataEC50:  0.0464nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235785(CVD-0019439 | US9359399, 2)copy SMILEScopy InChI
Affinity DataEC50:  0.0480nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235816(US9359399, 32)copy SMILEScopy InChI
Affinity DataEC50:  0.0485nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235799(US9359399, 11)copy SMILEScopy InChI
Affinity DataEC50:  0.0520nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235793(US9359399, 3)copy SMILEScopy InChI
Affinity DataEC50:  0.0520nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235800(US9359399, 12)copy SMILEScopy InChI
Affinity DataEC50:  0.0550nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235789(US9359399, 28)copy SMILES
Affinity DataEC50:  0.0582nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235783(US9359399, 4)copy SMILEScopy InChI
Affinity DataEC50:  0.0750nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235791(US9359399, 33)copy SMILEScopy InChI
Affinity DataEC50:  0.0767nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235797(US9359399, 9)copy SMILEScopy InChI
Affinity DataEC50:  0.0780nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235788(US9359399, 23)copy SMILEScopy InChI
Affinity DataEC50:  0.0910nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235809(US9359399, 22)copy SMILEScopy InChI
Affinity DataEC50:  0.0950nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235790(US9359399, 30)copy SMILES
Affinity DataEC50:  0.129nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235801(US9359399, 14)copy SMILEScopy InChI
Affinity DataEC50:  0.349nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235817(US9359399, 34)copy SMILEScopy InChI
Affinity DataEC50:  0.354nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235808(US9359399, 20)copy SMILEScopy InChI
Affinity DataEC50:  0.491nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50574769(CHEMBL4870603)copy SMILES
Affinity DataEC50:  0.5nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235807(US9359399, 21)copy SMILEScopy InChI
Affinity DataEC50:  0.732nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50574769(CHEMBL4870603)copy SMILES
Affinity DataEC50:  0.800nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM60212((4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(o...)copy SMILEScopy InChI
Affinity DataEC50:  0.810nMAssay Description:Agonist activity at mouse KOR expressed in CHO cells after 1.5 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PK0HTNPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235798(US9359399, 10)copy SMILEScopy InChI
Affinity DataEC50:  0.826nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50574769(CHEMBL4870603)copy SMILES
Affinity DataEC50:  0.900nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50574769(CHEMBL4870603)copy SMILES
Affinity DataEC50:  0.900nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50574769(CHEMBL4870603)copy SMILES
Affinity DataEC50:  0.900nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50586135(CHEMBL5088056)copy SMILES
Affinity DataEC50:  1nMAssay Description:Antagonist activity at mouse kappa opioid receptor expressed in CHO cell membranes assessed as reduction in U50,488H induced [35S]GTPgammaS binding i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21Z489FPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50574769(CHEMBL4870603)copy SMILES
Affinity DataEC50:  1nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235805(US9359399, 18)copy SMILEScopy InChI
Affinity DataEC50:  1.02nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50586129(CHEMBL5084538)copy SMILES
Affinity DataEC50:  1.70nMAssay Description:Antagonist activity at mouse kappa opioid receptor expressed in CHO cell membranes assessed as reduction in U50,488H induced [35S]GTPgammaS binding i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21Z489FPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50000296(CHEMBL441765 | CHEMBL482811 | U-50488H | US1149237...)copy SMILEScopy InChI
Affinity DataEC50:  1.70nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM235806(US9359399, 19)copy SMILEScopy InChI
Affinity DataEC50:  2.15nMT: 2°CAssay Description:Mouse R1.G1 cells (ATCC, Manassas, Va.) were grown in suspension in high glucose-DMEM (Dulbecco's Modified Eagle's Medium, Cellgro, Herndon, Va.) con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23B5Z2CUS Patent
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50002184(CHEMBL415330 | H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-A...)copy SMILEScopy InChI
Affinity DataEC50:  2.80nMAssay Description:Agonist activity at mouse KOR expressed in HEK293 cell assessed as inhibition of cAMP concentration incubated for 1 hrs by time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0R4NPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50574769(CHEMBL4870603)copy SMILES
Affinity DataEC50:  5nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM50586118(CHEMBL5083695)copy SMILES
Affinity DataEC50:  6.30nMAssay Description:Antagonist activity at mouse kappa opioid receptor expressed in CHO cell membranes assessed as reduction in U50,488H induced [35S]GTPgammaS binding i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21Z489FPubMed
TargetKappa-type opioid receptor(Mus musculus (Mouse))
Cara Therapeutics, Inc.

US Patent
LigandPNGBDBM214798(Dynorphin A (1-17) | YGGFLRRIRPKLK)copy SMILEScopy InChI
Affinity DataEC50:  6.70nMAssay Description:Positive allosteric modulator activity in mouse kappa opioid receptor stably expressed in HEK293 cell membrane assessed as inhibition of forskolin in...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD44CXPubMed
Displayed 1 to 50 (of 97 total ) | Next | Last >>
Jump to: